Member Info for Mozax

Bit early to tell what will happen in the US today but I do look at the pre- market trades, especially interesting when there is a lot of volume.

Yes, it’s sitting at 22p equivalent there currently.

This moves fast, and a few sells brings it down quickly too, down 17.1% on 361K traded is an example.

Be ready for it to move quickly in the other direction too.

Probably due an update soon.

And another 2. Hr 45 mins to run on the NASDAQ to go…..

It will be interesting to see if this continues to move up in the US after our market closes.

Could be interesting in the morning.

Now 22p equivalent, up 26% in the US.

And moving up strongly.

Nasdaq up at 40 cents now……20p equivalent

The ADS pre-market on the NASDAQ are already up 11% and rising fast at over 39 cents.

19.65 equivalent over here.

So get ready!

Equivalent in the US atm.

Moving up over there, 12%+ currently

Well, he’s suggesting testing 3p then possibly moving much higher in a month or so.

I felt that when hundreds of millions of warrants at 3p expired back in December 2023 we’d rerate to over 3p soon after.

Anyway, I’m keeping these tucked away in the ISA for at least 18 months, by then I’m confident revenues will really be growing very nicely with considerable AUM.

One of the Majors may want to snaffle us up and a PE valuation on rock steady annual revenues in excess of £50M could create some interesting figures.

Just buy & tuck away, like a number of huge holders have done here.

Takes a while to grow a big fat Turkey.

In the meantime £7.42M in Cash Jan 1st 2024

Increasing revenues

NO DEBT

Anticipating NO need for Further Equity CAPITAL.

Currently valued at less than cash.

Markets are weird atm.

Closed up 4.21% in the US yesterday at 0.3439 - equivalent to 17.2p over here.

If the US moves up again today then increasing Arbitrage opportunity.

It was interesting to have 85M traded in the US last week, I’m watching what’s going on over there with interest.

The 14 Million potential patients in the US isn’t finite.

These are annual ‘rolling’ numbers, unfortunately, such is the prevalence of CKD & Diabetes.

Then add in Global numbers.

So Davey, whilst you can ‘read a current report’ you may also need to ‘open your mind’ to future potential & a growing need for this proven technology.

This is why credible valuations in the millions/billions are assessed.

We are in a Global market.

I’m intrigued at the Discussion the BoD have had with the NASDAQ to stay the de-listing, in regards to the evidence supporting the reason the share price is only ‘temporarily’ likely to remain below $1 USD.

My view is that the buy out negotiations are substantially advanced and the figures being discussed support a much higher value than the current share price exhibits. The BoD would have confidentially demonstrated this evidence to the NASDAQ board.

The next few weeks here will be fascinating and also highly volatile I suspect.

I will ignore the temptation to trade and will wait out a potential sale, clearly Thursdays 85M in Volume was highly unusual, ( in the US) and yesterdays 5M reversed the initial 18% drop to end only 6% down at 0.349 Cents, or 17.5p UK equivalent.

The stock over here is very lightly traded but the market catches on, sometimes it can take a bit of time, and then suddenly……whoosh…..

I’ve been involved in these types of stocks before, and the key is to appreciate the potential Value, and wait for that value to be determined.

Apologies, I wasn’t looking at the ADS’s - got it.

Reason I ask is I looked at the pre-market info on the NASDAQ and it says ‘data not currently available’.

Do you have a link please Trax?

Davey, is there a technology Company out there for you to invest in that might help you become a bit more perky?

I’m sorry to hear of your sons illness.

It’s fantastic that Companies such as RENX exist and the team have had the conviction to develop the technology, and the market has supported it.

However, the market is tough and the Company have showed tremendous grit to get through the last few years.

I’m truly optimistic that the technology will survive, and that either alone, or via a buyout, shareholders will be very well rewarded for their support & patience.

And I sincerely hope that your Son will receive the help that he may need.

In other recent news, Renalytix, an AI-enabled in-vitro diagnostics company, announced that its kidneyintelX.dkd testing has received final Local Coverage Determination (LCD) from Medicare. The test, priced at $950, will be available for patients with Type 2 diabetes and Stage 1-3b Chronic Kidney Disease starting August 1, 2024.

Sales of their technology held up waiting for FDA approval, which they now have.

Market concerned about the Company’s cash situation as multiple Millions spent developing their technology.

The fact is that share prices can fall quickly and take time to recover.

With recent licensing & agreements The potential is in place for a rapid recovery, just needs the market to get behind us.

All the information is out there.

You might ask why it’s dropped from £12.00!